Latest Conference Articles

ASCVD in Women is Different: A Review of Pathophysiology, Risk Factors, Presentation

ASCVD in Women is Different: A Review of Pathophysiology, Risk Factors, Presentation

April 8th 2025

ACP

ACP 2025. Karol E Watson, MD, PhD, highlighted how traditional approaches to CV care have poorly addressed the unique presentations, risk factors, and pathophysiology of heart disease in women.

CVD Prevention in Older Adults: Crucial and Also Controversial

CVD Prevention in Older Adults: Crucial and Also Controversial

April 7th 2025

ACP

ACP 2025. Harvard gerontologist and preventive cardiologist Ariela Orkaby, MD, MPH, highlighted the many nuances required in the cardiovascular care of the aging population.

Shared Decision-Making in Lung Cancer Screening: A Collaborative Approach

Shared Decision-Making in Lung Cancer Screening: A Collaborative Approach

April 7th 2025

ACP

ACP 2025: Kim Sandler, MD, explains how primary care physicians can use shared decision-making to guide patients through lung cancer screening, emphasizing risk, benefit, follow-up, and smoking cessation.

Benefits of Lung Cancer Screening: A Conversation with Kim Sandler, MD

Benefits of Lung Cancer Screening: A Conversation with Kim Sandler, MD

April 7th 2025

ACP

ACP 2025: Kim Sandler, MD, sat down with Patient Care to discuss the benefits of lung cancer screening, citing a 20% reduction in lung cancer mortality with annual screenings.

"Allergic to Everything"

"Allergic to Everything"

April 5th 2025

ACP

ACP 2025. Scripps Clinic's John M Kelso, MD, offered topline updates on all types of allergies including a step-by-step on how to "delabel" patients identified as penicillin-allergic.

Peripheral Arterial Disease in the US: Amputation is Not the Answer

Peripheral Arterial Disease in the US: Amputation is Not the Answer

April 5th 2025

ACP

Foluso A. Fakorede, MD, sketched a disturbing picture of recognition and management of PAD in the US, highlighting stark racial and ethnic disparities and making an urgent call to action.

Colorectal Cancer Screening in 2025: Disparities Remain Persistent and Significant

Colorectal Cancer Screening in 2025: Disparities Remain Persistent and Significant

April 4th 2025

ACP

The highest CRC mortality rates occur at the “intersection of race, place, and class," Rachel Issaka, MD, MAS, told internal medicine clinicians at the annual ACP meeting.

Switching to Tirzepatide Outweighs Escalating Dulaglutide Dose in T2D: SURPASS-SWITCH Trial

Switching to Tirzepatide Outweighs Escalating Dulaglutide Dose in T2D: SURPASS-SWITCH Trial

April 4th 2025

ACP

Breaking research presented at ACP Internal Medicine 2025 showed that switching GLP1-RAs resulted in better glucose and weight control among adults with inadequately controlled T2D.

Lung Cancer Screening: A Missed Opportunity for Early Detection

Lung Cancer Screening: A Missed Opportunity for Early Detection

April 4th 2025

ACP

ACP 2025: Kim Sandler, MD, discussed the latest screening guidelines, real-world challenges in implementation, and the essential role of shared decision-making.

Prediabetes is Not A Benign Condition, Warned Samuel Dagogo-Jack, MD, MSc, at ACP 2025

Prediabetes is Not A Benign Condition, Warned Samuel Dagogo-Jack, MD, MSc, at ACP 2025

April 4th 2025

ACP

Dagogo-Jack reviewed alarming data on the damage prediabetes can inflict even decades before a diabetes diagnosis and offered guidance to the internal medicine audience.